New eye drop trial offers hope for cornea damage patients
Disease control
AVAILABLE
This trial provides access to experimental BRM421 eye drops for adults with mild to moderate limbal stem cell deficiency, a condition that can damage the cornea and affect vision. Participants will use the drops twice daily for at least 12 weeks and visit the clinic monthly for c…
Sponsor: BRIM Biotechnology Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC